Skip to content
SafetyScorer

Is Lamotrigine safe?

Lamotrigine

Lamotrigine (Lamictal) treats epilepsy and prevents mood episodes in bipolar disorder. Most people tolerate it well and it is not addictive. Its boxed warning is for rare but life-threatening rashes such as Stevens-Johnson syndrome, so the dose is built up slowly over weeks.

High confidence#57 of 82 medications
Updated
Spot a mistake?

#57of 82 medications

High confidence
Brands
Lamictal, Lamictal XR, Lamictal ODT, many generics
Uses
Epilepsy (adults and children from 2 years); bipolar I maintenance in adults
Bipolar titration (US label, no valproate)
25 mg a day weeks 1 to 2, 50 mg weeks 3 to 4, 100 mg week 5, 200 mg from week 6
With valproate
Half the dose and slower steps, starting at 25 mg every other day
Boxed warning
Serious skin rashes, including Stevens-Johnson syndrome and toxic epidermal necrolysis
Serious rash rate (label)
About 0.08% to 0.3% in adults, 0.3% to 0.8% in children
Controlled substance
No
US prescriptions (2024)
About 12.6 million, ranked 56th (ClinCalc)

How the score breaks down

The overall score is the weighted average of these factors. Scoring rules

  • Serious side effects30% of score

    55 out of 100, Fair

    Boxed warningThe strongest safety warning the US FDA puts on a medicine's label, printed inside a black border at the top.More in the glossary for serious rash needing hospital care in about 0.08% to 0.3% of adults and 0.3% to 0.8% of children, with rare deaths from SJS/TEN. The label also lists HLH, DRESS, blood disorders, aseptic meningitis and arrhythmia risk in heart disease.

  • Overdose margin20% of score

    65 out of 100, Fair

    The Lamictal label reports overdoses of up to 15 g, some fatal, with seizures, coma and widened QRS (intraventricular conduction delay). There is no antidote, and the label advises hospital admission after a suspected overdose.

  • Interactions15% of score

    55 out of 100, Fair

    Valproate slightly more than doubles lamotrigine levels and raises rash risk; carbamazepine, phenytoin, rifampin and some HIV drugs lower them. Oestrogen pills cut levels about 50%, with a rise in the pill-free week. Dofetilide is not recommended.

  • Dependence and misuse15% of score

    85 out of 100, Excellent

    Not a Controlled substanceA medicine or drug that the law restricts because it can be misused or cause dependence. Countries group them into schedules or classes.More in the glossary, with no sign of misuse. Stopping suddenly can trigger seizures in epilepsy (two seizures after abrupt withdrawal in bipolar trials), so the label advises tapering over at least 2 weeks.

  • Regulatory warnings10% of score

    40 out of 100, Weak

    Boxed rash warning, updated in October 2025 to name the HLA-B*1502 gene variant. The FDA warned on 31 March 2021 of possible serious arrhythmias in people with heart disease. The label also warns of medication errors from name confusion.

  • Track record10% of score

    92 out of 100, Excellent

    Lamictal was approved in the US on 27 December 1994 (NDA 020241) and had about 12.6 million US prescriptions in 2024. MHRA's 2021 review cited more than 12,000 monotherapy-exposed pregnancies, one of the largest pregnancy datasets of any medicine.

Is lamotrigine safe?

For most people with epilepsy or bipolar disorder it is one of the better tolerated long-term options, provided the dose is built up exactly as prescribed. Lamotrigine, sold as Lamictal, is not addictive and has unusually strong pregnancy safety data for an epilepsy drug. It was filled about 12.6 million times in the US in 2024.

The main worry is a rare, potentially fatal skin reaction, which is why it carries a Boxed warningThe strongest safety warning the US FDA puts on a medicine's label, printed inside a black border at the top.More in the glossary and why the starting schedule is so slow. We score it 64: below gabapentin (66) and above quetiapine (55) and lithium (51), the other common bipolar options.

The rash warning and why the dose starts low

The US label puts the rate of serious rash needing hospital care and stopping the drug at about 0.08% to 0.3% in adults and 0.3% to 0.8% in children aged 2 to 17. These include Stevens-Johnson syndrome and toxic epidermal necrolysis, in which the skin and mouth lining blister and peel. In a cohort of 1,983 children with epilepsy there was one rash-related death, and rare deaths have been reported in adults.

The label names four things that raise the risk:

  • taking valproate at the same time
  • starting above the recommended dose
  • increasing faster than the recommended schedule
  • carrying the HLA-B*1502 gene variant (found mainly in people of Han Chinese and Thai origin), which roughly doubles or triples the risk; the Boxed warningThe strongest safety warning the US FDA puts on a medicine's label, printed inside a black border at the top.More in the glossary, updated in October 2025, now names it

Nearly all life-threatening rashes begin 2 to 8 weeks after starting, though some have appeared after 6 months. Because it is not possible to tell early which rash will turn serious, the label says to stop lamotrigine at the first sign of a rash unless it is clearly due to something else. Ring your prescriber that day.

For adults with bipolar disorder who take neither valproate nor enzyme-inducing drugs, the US label schedule is:

WeeksDaily dose
1 and 225 mg
3 and 450 mg
5100 mg
6 onwards200 mg (target)

With valproate everything is halved, starting at 25 mg every other day. If you stop for longer than about five half-lives (a few days), the label says to restart from the beginning of the schedule.

Valproate, the pill and other interactions

Lamotrigine is broken down by glucuronidation, and drugs that speed or slow that process shift its levels a lot:

  • Valproate (Depakote, Epilim) slightly more than doubles lamotrigine levels and raises the rash rate. In epilepsy trials, 1% of people on both were hospitalised with rash, against 0.16% without valproate.
  • Oestrogen-containing pills cut lamotrigine levels by about half; during the pill-free week levels can nearly double, causing dizziness, unsteadiness or double vision. See combined oral contraceptives.
  • Carbamazepine, phenytoin, phenobarbital, rifampin and some HIV medicines lower lamotrigine levels, so higher doses are needed.
  • Dofetilide is not recommended with lamotrigine, and other sodium channel blockers may add to the heart rhythm risk.

Starting or stopping any of these needs a dose review.

Heart rhythm in people with heart disease

Laboratory studies found that lamotrigine blocks heart sodium channels in the same way as class IB antiarrhythmic drugs, at normal blood levels. On 31 March 2021 the FDA warned that this could slow conduction and trigger serious arrhythmias or sudden death in people with significant heart disease: heart failure, valve disease, congenital heart disease, conduction problems, Brugada syndrome or significant coronary disease. Combining it with other sodium channel blockers may add to the risk. In a study of healthy volunteers, normal doses did not slow conduction, so the warning is aimed at people with heart disease.

Other serious risks

Rarer warnings on the label include haemophagocytic lymphohistiocytosis (HLH), an overactive immune response that can be fatal; multi-organ allergic reactions (DRESS); low blood counts; aseptic meningitis; and a small rise in suicidal thoughts shared by all antiseizure drugs. Common side effects in epilepsy trials were dizziness, headache, double vision, unsteadiness, nausea and blurred vision; in bipolar trials, nausea, insomnia and sleepiness. Name confusion with other medicines has led to dispensing errors, so check your tablets.

In overdose, the label reports cases of up to 15 g, some fatal, with seizures, coma and conduction delay on the heart trace. Anyone who takes too much needs hospital assessment: in the US call Poison Help on 1-800-222-1222, in the UK 111, or 999 if someone is drowsy or fitting.

Pregnancy

A 2021 MHRA review concluded that lamotrigine and levetiracetam are the safer of the antiepileptic drugs reviewed in pregnancy. Studies covering more than 12,000 pregnancies on lamotrigine alone showed no increased risk of major birth defects at maintenance doses. The US label cites registry rates of 2.0% to 2.9%, close to the general population, with one registry finding a small rise in cleft lip or palate. Lamotrigine levels can fall during pregnancy and recover after delivery, so doses need monitoring. Anyone planning a pregnancy should see their specialist first, and the MHRA advises 5 mg of folic acid a day before conception.

Who should be careful

Talk to your doctor or pharmacist before starting lamotrigine, or before changing other medicines, if you take valproate, carbamazepine, phenytoin or a hormonal contraceptive, have had a rash with another antiseizure drug, have heart disease, or are pregnant or planning to be. Do not stop it suddenly; with epilepsy, abrupt withdrawal can cause seizures.

How we scored it

Track record (92) and dependence (85) are strong. Serious side effects (55) and regulatory warnings (40) reflect the boxed rash warning, the 2021 heart rhythm warning and rare immune reactions. Interactions (55) reflect the large dose effects of valproate, oestrogen and enzyme-inducing drugs, while the Overdose marginHow far a normal dose is from a harmful one. A wide margin means an accidental extra dose is unlikely to cause serious harm.More in the glossary (65) reflects fatal cases at very high doses.

Questions people ask

What does a lamotrigine rash look like?

Most rashes on lamotrigine are harmless, but the label says it is not possible to tell early on which will become serious. Warning signs are a spreading rash with blisters, peeling skin, sores in the mouth, eyes or genitals, fever or swollen glands. Nearly all life-threatening rashes start within 2 to 8 weeks of starting. Contact your prescriber the same day about any new rash.

Why do you have to increase lamotrigine slowly?

The risk of serious rash rises when the starting dose or the pace of increases goes above the label. For bipolar disorder without interacting drugs, the US label starts at 25 mg a day and reaches 200 mg only in week 6. Starter kits help people follow the steps. If you miss doses for several days, ask before restarting, because you may need to start again from the low dose.

Can you take lamotrigine with valproate (Depakote)?

Yes, but valproate slows the breakdown of lamotrigine and slightly more than doubles its blood levels. It also raises the rate of serious rash. The label therefore halves the doses and slows the build-up, starting at 25 mg every other day. Never add or stop valproate without your prescriber adjusting lamotrigine.

Is lamotrigine safe in pregnancy?

It is one of the better studied options. A 2021 MHRA review of more than 12,000 pregnancies found no increased risk of major birth defects at maintenance doses, and the US label cites registry rates of 2.0% to 2.9%, similar to the general population. One registry found a small rise in cleft lip or palate. Levels can fall in pregnancy, so doses are reviewed; see your specialist before trying to conceive.

Does the pill affect lamotrigine?

Yes. Contraceptive pills containing oestrogen roughly halve lamotrigine levels, and levels can almost double during the pill-free week, causing dizziness or double vision. Most people need a dose change when starting or stopping such a pill. Tell your prescriber about any hormonal contraception or HRT.

Is lamotrigine safe for your heart?

The warning is aimed at people with significant heart disease. Laboratory studies show lamotrigine acts on heart sodium channels like a class IB antiarrhythmic, and in March 2021 the FDA warned that it could cause serious arrhythmias in people with heart failure, valve disease, conduction problems or significant coronary disease. Your doctor may weigh this before prescribing.

Sources

  1. 1.LAMICTAL (lamotrigine) tablets, chewable dispersible tablets and orally disintegrating tablets prescribing information (opens in a new tab) · DailyMed / GlaxoSmithKline, 2025
  2. 2.Lamictal (lamotrigine): Drug Safety Communication - Studies show increased risk of heart rhythm problems in patients with heart disease (opens in a new tab) · US Food and Drug Administration, 2021
  3. 3.Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review (opens in a new tab) · MHRA Drug Safety Update, 2021
  4. 4.Drugs@FDA, NDA 020241 (Lamictal) (opens in a new tab) · US Food and Drug Administration, 2026
  5. 5.Lamotrigine drug usage statistics, United States, 2014 to 2024 (opens in a new tab) · ClinCalc DrugStats (MEPS data), 2026
Spot a mistake?